Procurement of Antiretroviral, Anti-Tuberculosis and Anti-Malarial Drugs (Annual Requirements) Mhpq/Pharm/2024-2025/Q75 Oib

MauritiusTenders notice for Procurement of Antiretroviral, Anti-Tuberculosis and Anti-Malarial Drugs (Annual Requirements) Mhpq/Pharm/2024-2025/Q75 Oib. The reference ID of the tender is 109827881 and it is closing on 09 Dec 2024.

100% Secure Payments

Tender Details

  • Country: Mauritius
  • Summary: Procurement of Antiretroviral, Anti-Tuberculosis and Anti-Malarial Drugs (Annual Requirements) Mhpq/Pharm/2024-2025/Q75 Oib
  • MUT Ref No: 109827881
  • Deadline: 09 Dec 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: HEALTH/IFB/2024/1977
  • Purchaser's Detail :
  • Purchaser : Chandrakant RAMPEARA
    Mauritius
    [Disclaimer: For Exact Organization/Tendering Authority details, please refer the tender notice.]

  • Description :
  • PROCUREMENT OF ANTIRETROVIRAL, ANTI-TUBERCULOSIS AND ANTI-MALARIAL DRUGS (ANNUAL REQUIREMENTS) MHPQ/PHARM/2024-2025/Q75 OIB
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
MauritiusTenders Features

MauritiusTenders Features

Fresh and verified Tenders from Mauritius. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Mauritius in your email inbox.

  Chat with us